Concepedia

Muralidhar Mallem

MM

8

Publications

468

Citations

8

H-Index

2008

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Muralidhar Mallem is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in engineering, biotechnology, and biochemical engineering.

Top concepts

Publications per year

2008–2014

8

Publications

8

Production of monoclonal antibodies by glycoengineered Pichia pastoris

Thomas I. Potgieter, Michael Cukan, J. E. Drummond et al. · Journal of Biotechnology · 2008 · 157 citations

, , +4

Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study

Ningyan Zhang, Calin Dan Dumitru, Nga Rewa Houston Cummings et al. · mAbs · 2011 · 92 citations · Full text

Antibody expression kinetics in glycoengineered <i>Pichia pastoris</i>

Thomas I. Potgieter, Sean D. Kersey, Muralidhar Mallem et al. · Biotechnology and Bioengineering · 2010 · 62 citations

, , +17

Improved production of monoclonal antibodies through oxygen-limited cultivation of glycoengineered yeast

Marina Berdichevsky, Marc d′Anjou, Muralidhar Mallem et al. · Journal of Biotechnology · 2011 · 39 citations

, , +11

Optimization of erythropoietin production with controlled glycosylation-PEGylated erythropoietin produced in glycoengineered Pichia pastoris

Juergen H. Nett, Sujatha Gomathinayagam, Stephen R. Hamilton et al. · Journal of Biotechnology · 2011 · 38 citations

, , +10

Rows per page

1–5 of 8